Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis.

× No keyword cloud information.

44 in total

1. Is prolonged rotavirus infection a common cause of protracted diarrhoea?

Authors: M Sood; I W Booth
Journal: Arch Dis Child Date: 1999-04 Impact factor: 3.791

2. Evidence for using nebulised antibiotics in cystic fibrosis.

Authors: S P Conway
Journal: Arch Dis Child Date: 1999-04 Impact factor: 3.791

3. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa.

Authors: L Zhang; P Dhillon; H Yan; S Farmer; R E Hancock
Journal: Antimicrob Agents Chemother Date: 2000-12 Impact factor: 5.191

4. Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.

Authors: N M Byrne; P M Keavey; J D Perry; F K Gould; D A Spencer
Journal: Arch Dis Child Date: 2003-08 Impact factor: 3.791

Review 5. Polymyxins revisited.

Authors: David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal: Clin Microbiol Rev Date: 2008-07 Impact factor: 26.132

6. Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.

Authors: Stephanie J Wallace; Jian Li; Craig R Rayner; Kingsley Coulthard; Roger L Nation
Journal: Antimicrob Agents Chemother Date: 2008-07-07 Impact factor: 5.191

Review 7. Microbiology of cystic fibrosis lung infections: themes and issues.

Authors: J R Govan; J W Nelson
Journal: J R Soc Med Date: 1993 Impact factor: 5.344

8. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients.

Authors: M Denton; N J Todd; J M Littlewood
Journal: Eur J Clin Microbiol Infect Dis Date: 1996-05 Impact factor: 3.267

9. Aztreonam lysine for inhalation solution in cystic fibrosis: profile report.

Authors: Greg L Plosker
Journal: Paediatr Drugs Date: 2011-04-01 Impact factor: 3.022

10. Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation.

Authors: E Ring; E Eber; W Erwa; M S Zach
Journal: Arch Dis Child Date: 1998-06 Impact factor: 3.791